Evidence map›Paper›PMID 42820044›Full record

ArticleParkinson's disease2026

Peripheral

Shuning Wang, Hang Shi, Xiangjun Meng, Hui Zhu

Abstract read
In one paragraph

Article in Parkinson's disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shuning WangDepartment of Neurology The First Hospital of Jilin University Changchun Jilin China jlu.edu.cn.ORCID https://orcid.org/0009-0008-0354-1239
Hang ShiDepartment of Neurology Changchun Central Hospital Changchun Jilin China.ORCID https://orcid.org/0009-0000-5306-5885
Xiangjun MengDepartment of Neurology Liaoyuan Central Hospital Liaoyuan Jilin China.ORCID https://orcid.org/0009-0001-6841-749X
Hui ZhuDepartment of Neurology The First Hospital of Jilin University Changchun Jilin China jlu.edu.cn.ORCID https://orcid.org/0009-0006-9173-6831

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Accumulating evidence implicates peripheral immune dysregulation in the pathogenesis of Parkinson's disease (PD). High-mobility group box 1 (HMGB1), a key alarmin released during mitochondrial stress, has been reported to be upregulated in the peripheral blood of PD patients, yet its precise role remains unclear. Methods: We performed an integrated analysis of multiple transcriptomic datasets from peripheral blood mononuclear cells (PBMCs) of PD patients. Using a combination of methods including machine learning, cell-cell communication analysis, in silico gene perturbation, and pathway enrichment analysis, we systematically investigated the expression and regulation of Results: We found that Conclusion: Our analysis revealed a distinct downregulation of

Indexed as

high-mobility group box 1IL-17 signaling pathwayParkinson’s diseaseperipheral immunityS100 gene familysingle-cell RNA sequencing

Identifiers

PMID42820044
PMCPMC13625826

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.